ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹27,637 Cr | ₹24,494 Cr | ₹26,700 Cr | ₹22,810 Cr | ₹22,834 Cr |
What is the latest Total Liabilities ratio of ZYDUS LIFESCIENCES ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹27,637 Cr |
Mar2023 | ₹24,494 Cr |
Mar2022 | ₹26,700 Cr |
Mar2021 | ₹22,810 Cr |
Mar2020 | ₹22,834 Cr |
How is Total Liabilities of ZYDUS LIFESCIENCES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹27,637 Cr | 12.83 | |
Mar2023 | ₹24,494 Cr | -8.26 | |
Mar2022 | ₹26,700 Cr | 17.05 | |
Mar2021 | ₹22,810 Cr | -0.10 | |
Mar2020 | ₹22,834 Cr | - |
Compare Total Liabilities of peers of ZYDUS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ZYDUS LIFESCIENCES | ₹95,458.2 Cr | -1% | -4% | 48.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,352.0 Cr | 1.7% | -4.7% | 48.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,265.0 Cr | 4.4% | 3.1% | 66% | Stock Analytics | |
CIPLA | ₹120,035.0 Cr | -0.9% | -1.7% | 17.3% | Stock Analytics | |
MANKIND PHARMA | ₹102,231.0 Cr | -2.1% | -0.6% | 33.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,286.0 Cr | -1% | -8.9% | 6.5% | Stock Analytics |
ZYDUS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ZYDUS LIFESCIENCES | -1% |
-4% |
48.4% |
SENSEX | 1.8% |
-2.5% |
19.9% |
You may also like the below Video Courses